Thomas Jefferson University
Jefferson College of Health Professions
Medical Laboratory Sciences & Biotechnology

Zorina, Tatiana

< Back

Profile

tdz002

Tatiana Zorina, MD, PhD, CT(ASCP)

Contact Dr. Zorina

130 South Ninth Street
Suite 1924
Philadelphia, PA 19107

(215) 503-8182
(215) 503-2189 fax

Medical School

PhD, Immunology, Institute of Experimental Medicine, St. Petersburg, Russia - 1987
MD, Internal Medicine, University of St. Petersburg, St. Petersburg, Russia - 1974
Certificate, Cytology, University of Pittsburgh Medical Center, Pittsburgh, PA - 2005

Board Certification

CT(ASCP) #CT-014006, 2011
Cytotechnologist, CA License ID: CLM1249, 2011
ThinPrep Pap Test Training Program Certificate, Anisa I. Kanbour

Research and Clinical Interests

T regulatory cells trafficking in Type 1 Diabetes
Gene and Cell Based Approaches for abrogation of Autoimmunity in Type 1 Diabetes

Professional Societies

American Society for Clinical Pathology, 2005- present
American Society of Cytopathology, 2009-present

Publications

Most Recent Peer-Reviewed Publications

  1. Cell-based immunomodulatory therapy approaches for type 1 diabetes mellitus
  2. Genetic profile considerations for induction of allogeneic chimerism as a therapeutic approach for type 1 diabetes mellitus
  3. Infectious diseases in cancer patients: An overview
  4. Treg cells in pancreatic lymph nodes: The possible role in diabetogenesis and β cell regeneration in a T1D model
  5. Regulation of dendritic cell expansion in aged athymic nude mice by FLT3 ligand
  6. Recovery of the endogenous β cell function in the NOD model of autoimmune diabetes
  7. Transplanted hematopoietic cells seed in clusters in recipient bone marrow in vivo
  8. Distinct characteristics and features of allogeneic chimerism in the NOD mouse model of autoimmune diabetes
  9. Effect of FLT3 ligand and granulocyte colony-stimulating factor on expansion and mobilization of facilitating cells and hematopoietic stem cells in mice: Kinetics and repopulating potential
  10. Development of dendritic cell-based genetic vaccines for cancer
  11. FLT3 ligand induces the generation of functionally active dendritic cells in mice
  12. Bone marrow-derived dendritic cells serve as potent adjuvants for peptide-based antitumor vaccines
  13. Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity
  14. The effect of the bone marrow fibroblasts from patients with malignant diseases of the blood system on the colony-forming capacity of granulomonocytic precursor cells | Vliianie fibroblastov kostnogo mozga bol'nykh zlokachestvennymi zabolevaniiami sistemy krovi na kolonieobrazuiushchuiu sposobnost' granulomonotsitarnykh kletok-predshestvennikov.